Rajan Sharma
Stock Analyst at Goldman Sachs
(0.27)
# 4,274
Out of 4,974 analysts
5
Total ratings
25%
Success rate
-11.79%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rajan Sharma
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Reinstates: Sell | $7.25 | $8.97 | -19.14% | 1 | May 29, 2025 | |
| AZN AstraZeneca | Initiates: Buy | $97 | $81.70 | +18.73% | 1 | May 30, 2024 | |
| GSK GSK plc | Initiates: Neutral | $47 | $40.50 | +16.05% | 1 | May 30, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Overweight | $79 | $37.20 | +112.37% | 2 | Jun 20, 2023 |
DBV Technologies
May 29, 2025
Reinstates: Sell
Price Target: $7.25
Current: $8.97
Upside: -19.14%
AstraZeneca
May 30, 2024
Initiates: Buy
Price Target: $97
Current: $81.70
Upside: +18.73%
GSK plc
May 30, 2024
Initiates: Neutral
Price Target: $47
Current: $40.50
Upside: +16.05%
Immunocore Holdings
Jun 20, 2023
Reiterates: Overweight
Price Target: $79
Current: $37.20
Upside: +112.37%